OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Orexin Receptor Antagonists
J.A. Christopher
Pharmaceutical Patent Analyst (2012) Vol. 1, Iss. 3, pp. 329-346
Closed Access | Times Cited: 13
J.A. Christopher
Pharmaceutical Patent Analyst (2012) Vol. 1, Iss. 3, pp. 329-346
Closed Access | Times Cited: 13
Showing 13 citing articles:
Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies
Danielle K. Sandsmark, Jonathan E. Elliott, Miranda M. Lim
SLEEP (2017)
Open Access | Times Cited: 172
Danielle K. Sandsmark, Jonathan E. Elliott, Miranda M. Lim
SLEEP (2017)
Open Access | Times Cited: 172
Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Selective orexin receptor antagonists
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties
J.A. Christopher, Sarah J. Aves, Jason Brown, et al.
MedChemComm (2015) Vol. 6, Iss. 5, pp. 947-955
Closed Access | Times Cited: 17
J.A. Christopher, Sarah J. Aves, Jason Brown, et al.
MedChemComm (2015) Vol. 6, Iss. 5, pp. 947-955
Closed Access | Times Cited: 17
Discovery of substituted lactams as novel dual orexin receptor antagonists. Synthesis, preliminary structure–activity relationship studies and efforts towards improved metabolic stability and pharmacokinetic properties. Part 1
Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 4, pp. 1201-1208
Closed Access | Times Cited: 16
Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 4, pp. 1201-1208
Closed Access | Times Cited: 16
Structure–activity relationship studies and sleep-promoting activity of novel 1-chloro-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 2
Thierry Sifferlen, Ralf Koberstein, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 13, pp. 3857-3863
Closed Access | Times Cited: 13
Thierry Sifferlen, Ralf Koberstein, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 13, pp. 3857-3863
Closed Access | Times Cited: 13
Small-molecule Antagonists of the Orexin Receptors
J.A. Christopher
Pharmaceutical Patent Analyst (2014) Vol. 3, Iss. 6, pp. 625-638
Closed Access | Times Cited: 12
J.A. Christopher
Pharmaceutical Patent Analyst (2014) Vol. 3, Iss. 6, pp. 625-638
Closed Access | Times Cited: 12
Synthesis, structure–activity relationship studies, and identification of novel 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 1
Thierry Sifferlen, Ralf Koberstein, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 7, pp. 2212-2216
Closed Access | Times Cited: 11
Thierry Sifferlen, Ralf Koberstein, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 7, pp. 2212-2216
Closed Access | Times Cited: 11
Expression of orexin-A (hypocretin-A) in the hypothalamus after traumatic brain injury: A postmortem evaluation
Chrysavgi Kousi, Evangeli Lampri, Spyridon Voulgaris, et al.
Forensic Science International (2021) Vol. 327, pp. 110961-110961
Closed Access | Times Cited: 6
Chrysavgi Kousi, Evangeli Lampri, Spyridon Voulgaris, et al.
Forensic Science International (2021) Vol. 327, pp. 110961-110961
Closed Access | Times Cited: 6
Treatment and prevention of various therapeutic conditions using OX receptor antagonistic activity (WO2012081692)
J.A. Christopher, Miles Congreve
Expert Opinion on Therapeutic Patents (2013) Vol. 23, Iss. 2, pp. 273-277
Closed Access | Times Cited: 3
J.A. Christopher, Miles Congreve
Expert Opinion on Therapeutic Patents (2013) Vol. 23, Iss. 2, pp. 273-277
Closed Access | Times Cited: 3
Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934)
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2015) Vol. 26, Iss. 3, pp. 409-415
Closed Access | Times Cited: 1
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2015) Vol. 26, Iss. 3, pp. 409-415
Closed Access | Times Cited: 1
Synthesis of new tetrahydropyridopyrazine derivatives via continuous flow chemistry approach and their spectroscopic characterizations
Nilesh D. Parmar, Sanjay Hadiyal, Vimal H. Kapupara, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 7, pp. 1437-1445
Closed Access
Nilesh D. Parmar, Sanjay Hadiyal, Vimal H. Kapupara, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 7, pp. 1437-1445
Closed Access
